To determine if DKK1 modulates the immune landscape of the tumor microenvironment, we profiled the tumor-infiltrating immune populations from IgG or mDKN01-treated mice via flow cytometry, 16 days post tumor inoculation. Here, DKK1 is linked to neoplasm.